INTELLIA THERAPEUTICS, INC. Shareholders' Equity
INTELLIA THERAPEUTICS, INC. (NTLA) had Shareholders' Equity of $727.71 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $727.71M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $620.94M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $671.39M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $748.42M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $727.71M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $620.94M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $671.39M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $748.42M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | -$715.25M 10-Q · filed 2026-08-06 | $715.25M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $779.92M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $871.96M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $962.62M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $971.06M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $1.04B 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $1.05B 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.04B 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.10B 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $1.19B 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $1.24B 10-K · filed 2026-02-26 | |
| 2022-09-30 | $824.95M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $880.55M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $953.75M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $1.04B 10-K · filed 2025-02-27 | |
| 2021-09-30 | $1.11B 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $494.81M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $545.87M 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $527.07M 10-K · filed 2024-02-22 | |
| 2020-09-30 | $329.62M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $351.59M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $247.76M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $269.88M 10-K · filed 2023-02-23 | |
| 2019-09-30 | $275.65M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $276.87M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $264.34M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $277.92M 10-K · filed 2022-02-24 | |
| 2018-09-30 | $263.27M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $279.34M 10-Q · filed 2019-10-31 | |
| 2018-03-31 | $295.50M 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $300.60M 10-K · filed 2021-02-26 | |
| 2017-09-30 | $175.85M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $187.59M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $199.88M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $209.84M 10-K · filed 2020-02-27 | |
| 2016-09-30 | $218.12M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $223.60M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | -$27.14M 10-Q · filed 2016-06-03 | |
| 2015-12-31 | -$21.20M 10-K · filed 2019-02-27 | |
| 2014-12-31 | $7.57M 10-K · filed 2018-03-14 | |
| 2014-05-06 | $0.00 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |